Skip to Content

Anticoagulant Citrate Dextrose A

Generic Name: anhydrous citric acid, dextrose monohydrate, and trisodium citrate dihydrate
Dosage Form: solution

Description

Anticoagulant Citrate Dextrose Solution, Solution A, U.S.P., (ACD-A), is a sterile, non-pyrogenic solution of citric acid, sodium citrate, and dextrose, in water for injection. Each 10 mL of solution contains:

Citric Acid, anhydrous, USP 0.073 g
Sodium Citrate, dihydrate, USP 0.220 g
Dextrose, monohydrate, USP 0.245 g
Water for Injection, USP q.s.
pH:   4.5 – 5.5

Single patient use only, on a single occasion.

Clinical Pharmacology

ACD-A acts as an anticoagulant by the action of the citrate ion chelating free ionized calcium, thus making calcium unavailable to the coagulation system.

Indications and Usage

Anticoagulant Citrate Dextrose Solution, Solution A, U.S.P. (ACD-A), is intended for use as an anticoagulant in the extracorporeal blood processing with Autologous PRP Systems in production of platelet rich plasma (PRP). Refer to the manufacturer's Operator's Manual of the Autologous PRP System for the Directions for Use.

Contraindications

NOT FOR DIRECT INTRAVENOUS INFUSION

Warnings

NOT FOR DIRECT INTRAVENOUS INFUSION

Precautions

General

  • Aseptic technique must be maintained at all times.
  • ACD-A solution is a clear and colorless solution. If the product shows any cloudiness or turbidity, the product should be discarded.
  • The closure system provides a biological barrier and should be intact – discard product if system is compromised.

Information for Patients

None.

Carcinogenesis, mutagenesis, impairment of fertility

Long-term studies in animals have not been performed to evaluate the carcinogenic potential of ACD-A.

Pregnancy

Long-term studies in animals have not been performed to evaluate the effects of ACD- A on pregnant women.

Pediatric Use

The safety and effectiveness of ACD-A in children have not been established.

Adverse Reactions

Not applicable. This product is used as an anticoagulant in the extracorporeal blood processing with Autologous PRP Systems in production of platelet rich plasma (PRP).

Overdosage

Not applicable. This product is used as an anticoagulant in the extracorporeal blood processing with Autologous PRP systems in production of platelet rich plasma (PRP).

Dosage and Administration

Refer to the manufacturer's Operator's Manual of the Autologous PRP System for the Directions for Use.

Rx only

Caution: Federal Law (US) restricts this devise to sale by or on the order of a Physician.

How Supplied

Anticoagulant Citrate Dextrose Solution, Solution A, U.S.P., (ACD-A)

  REF SIZE CASE
  PN 9350-10 30 mL 10 Vials/Case
  PN 9350-25 30 mL 25 Vials/Case

It is recommended that the product be stored at ambient room temperature, 24 °C (75 °F); however, the product can be stored between 15 °C (59 °F) and 30 °C (86 °F). Protect from freezing and exposure to excessive heat should be minimized.

Manufactured & Distributed by:
CitraLabs™
55 Messina Drive, Braintree, MA 02184
Phone Number: 1-800-299-3411

Authorized Representative:
Biomet U.K. Ltd.
Waterton Industrial Estate
Bridgend, South Wales, CF31 3XA
Great Britain
United Kingdom
Phone 441.65.66.55.221

PRINCIPAL DISPLAY PANEL - 10 Vial Case Label

C E 0044

ACD-A
Anticoagulant Citrate Dextrose Solution,
10 Vials / Case    Solution A, U.S.P., ACD-A, 30 mL

REF PN 9350-10
WARNING: NOT FOR DIRECT INTRAVENOUS INFUSION

Used as an anticoagulant in the extracorporeal blood processing with
Autologous PRP Systems in production of platelet rich plasma (PRP).
Refer to PRP Systems manufacturer's Directions for Use.

Manufactured & Distributed by:

CitraLabs
A Biomet Biologics Company

Citra Labs, LLC.
55 Messina Drive, Braintree, MA 02184
1-800-299-3411

EC REP
Authorized Representative:
Biomet U.K. Ltd.,
Waterton Industrial Estate
Bridgend, South Wales, CF31 3XA
Great Britain - United Kingdom
Phone 441.65.66.55.221

STERILE • NON-PYROGENIC

Composition per 10 mL of Solution:
Citric Acid, (Anhydrous), U.S.P.    0.073 g.
Sodium Citrate, (Dihydrate), U.S.P.    0.220 g.
Dextrose, (Monohydrate), U.S.P.    0.245 g.
CAUTION: Single Procedure Use-Discard Unused Portion
Do Not Use Unless Solution is Clear and Seal is Intact.
Store Between 15 °C - 30 °C (59 °F - 86 °F).
RX Only:

EXP DATE

LOT

LA9350-10B 02/15

Anticoagulant Citrate Dextrose A 
anhydrous citric acid, dextrose monohydrate, and trisodium citrate dihydrate solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:23731-6051
Route of Administration EXTRACORPOREAL DEA Schedule     
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
Dextrose Monohydrate (Anhydrous Dextrose) Dextrose Monohydrate 24.5 mg  in 1 mL
Anhydrous Citric Acid (Anhydrous Citric Acid) Anhydrous Citric Acid 7.3 mg  in 1 mL
Trisodium Citrate Dihydrate (Anhydrous Citric Acid) Trisodium Citrate Dihydrate 22 mg  in 1 mL
Packaging
# Item Code Package Description
1 NDC:23731-6051-3 30 mL in 1 VIAL, SINGLE-USE
2 NDC:23731-6051-1 10 VIAL, SINGLE-USE in 1 CASE
2 NDC:23731-6051-3 30 mL in 1 VIAL, SINGLE-USE
3 NDC:23731-6051-2 25 VIAL, SINGLE-USE in 1 CASE
3 NDC:23731-6051-3 30 mL in 1 VIAL, SINGLE-USE
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA BN020037 08/26/2003
Labeler - Citra Labs (962863838)
Establishment
Name Address ID/FEI Operations
Citra Labs 962863838 MANUFACTURE(23731-6051)
Revised: 03/2016
 
Citra Labs
Hide